*Some Market data delayed by 15 mins.

Tarsus Pharmaceuticals, Inc. Common Stock

Symbol: TARS (NASDAQ)
59.28 ▲ (3.37%) 1.935

Company Description:
Tarsus Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the development and commercialization of therapeutics, starting with eye care. The company is focused on the development and commercialization of first-in-class therapeutic candidates to provide treatment for ophthalmic conditions. The company's candidate XDEMVY is a novel investigational eye drop to treat blepharitis caused by the infestation of Demodex mites, referred to as Demodex blepharitis.

Key Stats
  • Today's Open: $57.54
  • Today's High: $59.413
  • Today's Low: $55.961
  • Today's Volume: 207.10K
  • Yesterday Close: $57.34
  • Yesterday High: $59.78
  • Yesterday Low: $56.96
  • Yesterday Volume: 559.73K
  • Last Min Volume: 651
  • Last Min High: $59.275
  • Last Min Low: $59.229
  • Last Min VWAP: $59.23463
Company Profile
  • Name: Tarsus Pharmaceuticals, Inc. Common Stock
  • Website: https://www.tarsusrx.com
  • Listed Date: 2020-10-16
  • Location: IRVINE, CA
  • Market Status: Active
  • CIK Number: 0001819790
  • SIC Code: 2836
  • SIC description: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
  • Market Cap: $2.42B
  • Round Lot: 100
  • Outstanding Shares: 42.21M
  • Asset Type: CS
RECENT FILINGS FOR TARS
Filing Date Filing Type Format
2025-09-26 4 View
2025-09-24 144 View
2025-09-18 4 View
2025-09-16 4 View
2025-09-10 4 View
2025-09-08 144 View
2025-08-14 SCHEDULE 13G/A View
2025-08-13 4 View
2025-08-11 144 View
2025-08-06 10-Q View
2025-08-06 8-K View
2025-07-28 SCHEDULE 13G View
2025-06-18 4 View
2025-06-18 8-K View
2025-06-17 144 View
2025-06-17 4 View
2025-06-16 4 View
2025-06-16 4 View
2025-06-16 4 View
2025-06-16 4 View

 

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money. Copyright© 2024, 247MarketNews inc.